CompuGroup Medical SE & Co. KGaA

DB:COPA Stock Report

Market Cap: €1.1b

CompuGroup Medical SE KGaA Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of COPA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies3,607,0006.97%
General Public8,250,99615.9%
Institutions12,819,86724.8%
Individual Insiders27,057,13752.3%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 79.39% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
34.7%
Frank Gotthardt
17,931,228€389.8m0%no data
6.97%
Scur-Alpha 269 GmbH
3,607,000€78.4m0%no data
6.92%
Daniel Gotthardt
3,578,723€77.8m0%no data
6.53%
Brigitte Gotthardt
3,379,905€73.5m0%no data
3.86%
Reinhard Koop
1,998,926€43.5m0%no data
3.08%
Putnam LLC
1,592,888€34.6m-1.91%0.03%
2.61%
Allianz Asset Management GmbH
1,352,374€29.4m0%0.01%
2.1%
Norges Bank Investment Management
1,085,512€23.6m0%no data
1.78%
The Vanguard Group, Inc.
919,804€20.0m0.02%no data
1.52%
Columbia Management Investment Advisers, LLC
784,984€17.1m0%no data
1.39%
Deka Investment GmbH
718,074€15.6m0%0.01%
1.18%
BlackRock, Inc.
610,402€13.3m0.24%no data
0.85%
Dimensional Fund Advisors LP
439,622€9.6m0.51%no data
0.84%
UBS Asset Management AG
436,740€9.5m-16.7%no data
0.81%
DNCA Finance
419,930€9.1m0%0.1%
0.72%
Invesco Ltd.
370,830€8.1m10.8%no data
0.56%
Threadneedle Asset Management Ltd
288,960€6.3m0%0.26%
0.49%
Lupus Alpha Asset Management GmbH
251,000€5.5m0%0.4%
0.46%
Universal Investment GmbH
237,101€5.2m0%0.08%
0.44%
Apo Asset Management GmbH
228,233€5.0m0%0.61%
0.38%
Pictet Asset Management Limited
194,576€4.2m0%no data
0.33%
BLI - Banque De Luxembourg Investments S.A.
170,164€3.7m0%0.04%
0.32%
MEAG MUNICH ERGO Asset Management GmbH
167,199€3.6m0%0.61%
0.32%
Lupus alpha Investment GmbH
166,000€3.6m0%0.86%
0.27%
Klaus Esser
140,000€3.0m0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 03:54
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

CompuGroup Medical SE & Co. KGaA is covered by 19 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Gerhard SchwarzBaader Helvea Equity Research
Knut WollerBaader Helvea Equity Research
Gunnar CohrsBerenberg